Workstream (OTCBB:WSTM – News), a leading provider of human capital management software and services, announced today that its Board of Directors has approved a one-for-four hundred reverse stock split of Workstream common stock. The company anticipates the stock split will be effective after the close of business May 6, 2011. Workstream stockholders had authorized the Board of Directors to approve a reverse stock split at a ratio of between one-for-two hundred and one-for-four hundred at the company’s April 29, 2011 Annual Shareholder’s Meeting.

When the reverse stock split becomes effective, every four hundred shares of issued and outstanding Workstream common stock will automatically be combined into one issued and outstanding share of common stock without any change in the par value of the shares. The number of authorized shares of the company’s common stock will also be proportionately reduced from 992,094,055 to 2,480,235.

No fractional share will be issued in connection with the reverse stock split. Stockholders who would otherwise hold a fractional share of the company’s common stock will receive a cash payment in lieu of such fractional share based upon the average closing bid prices of our common shares during each of the five traded days preceding the effective date of the reverse stock split.

About Workstream: Workstream provides a variety of solutions for recruitment, compensation planning, performance management, and talent management solutions and services that help companies manage the employee lifecycle. Workstream’s Talent Center enables employers to align their talent strategy with their business strategy. Solutions are offered as Software as a Service (SaaS.)

Advanced Cell Technology, a small Massachusetts-based biotechnology company that has struggled to bring human embryonic stem cells from the lab to the clinic, will begin recruiting 12 patients in Oregon and Massachusetts with a rare eye condition called Stargardt’s macular dystrophy.

What macular degeneration is? Due to this disease, the cells at the center part of your eye(Which is critical for focus) dies. As a result the patient becomes blind or near blind. If successfull, Advanced Cell technologies new research could brighten the lives of many.  

This is the most immediate promise of human embryonic stem cell research — that these immature cells can be coaxed partly down the road to becoming a desired tissue type, and in the process get other cells growing and renewing.

Advanced Cell Technology’s product is a human embryonic stem cell trained to become a retinal cell. For this first clinical trial, only a few thousand of these cells will be injected into one eye of each volunteer, mostly to check to see that it is safe.

ACT’s Dr. Robert Lanza says the doctors taking part in the trial will be able to watch it unfolding in real-time, because it is possible to look into the eye and see the cells taking up residence in the retina. And it will be possible to continuously check the vision of the patients, to see if it is improving.

Stargardt’s affects only 30,000 to 50,000 Americans, according to the American Macular Degeneration Foundation, but ACT has its sights set on a much larger market if this trial is successful — age-related macular degeneration.

This blinding condition affects more than 30 million people worldwide and is the leading cause of blindness in people over 60 in the United States. Many will be praying for the success of this clinical trial, as it can literarly brighten the lives of many thousnads in the world.

This fresh news caused the share to jump near 50%.  Currently shares are traded at .07 (7cents) per share.  It makes sense to invest in this as a couple of hundred dollers can buy you about 3000 shares. For an investor,  the success of this trial will give good returns in long term.  ACTC has around 958 million Shares Outstanding.

Advanced Cell Technology, Inc., a biotechnology company, focuses on the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The company’s cellular reprogramming involves in the development of therapies based on the use of genetically identical pluripotent stem cells generated by its cellular reprogramming technologies. Advanced Cell Technology, Inc. is also generating stable cell lines with particular focus on blood lineage and vascular epithelial cell lines from hemangioblast cells. In addition, it is developing an autologous myoblast transplantation therapy to restore cardiac function in patients with advanced heart disease. The company’s stem cell-based therapy would provide treatment for a range of acute and chronic degenerative diseases. Further, it develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. The company is headquartered in Worcester, Massachusetts.

Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The company’s products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and Crave-NX, a fat-free glucose spray that is used as an aid for dieters. Generex Biotechnology Corporation’s under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; morphine and fentanyl products for breakthrough and postoperative pain; and AE37, an immunotherapeutic vaccine that is in Phase II clinical trials for patients with HER-2/neu positive breast cancer. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S for the development of a metformin medicinal chewing gum.

1. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
2. The Company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company’s proprietary RapidMist™ device.
3. The Company’s flagship product, Buccal insulin, which has been approved in India, Lebanon, Algeria, and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world.
4. Distribution Agreement for Generex Oral-lyn in Chile.
5. Long-term marketing and distribution agreement for its glucose spray product with Merck S.A. de C.V. in Mexico.
6. The Company is continuing its work toward developing synthetic vaccines for both pandemic and seasonal influenza strains.
7. AE37 have the potential to completely change how breast cancer is treated. (according to Dr. Craig Eagle). AE37 as a preventative breast cancer vaccine should currently be valued over $1 billion.

Shares of Generex Biotechnology Corporation (NASDAQ:GNBT)  skyrocketed 16% with heavy volume to $.54 cents per share after the company announced that it has entered into a sales agreement with Elias Shaker & Company, to represent Generex’s novel consumer products to national and regional retail and wholesale accounts in the USA.

At the current price there is plenty of room for growth for this corporation. As of today’s stock market you can buy 2 shares for about a dollar. A good long term investment considering the above facts.

One World Ventures, Inc. (Pinksheets:OWVI) announced on 08/13/2010 that, it has successfully obtained funding to further expand the business operations in its effort to become more profitable and provide greater shareholder value. One World had increased the authorized shares by 500 million and was able to successfully place shares which will enable the company to take advantage of expansion opportunities and help achieve its growth goals.

“We are still a very young company, yet we are in the process of growing rapidly,” CEO Stephen Prior explained. “This influx of capital will allow us to focus on new 1World Cash locations as well as other opportunities.”
In an effort to become fully reporting and provide greater transparency, One World is pleased to announce that Baker Tilley, an international accounting firm located in Hong Kong, is completing the audit of the company’s financials. Once finished, One World will release the report at which stage the company will meet all the SEC requirements to be a fully reporting company.

In addition, the company is providing full accessibility of its transfer agent in Las Vegas, NV and can be reached for share structure details. As of Friday, August 13, 2010, the authorized share total is 2.5 billion, all of these shares are issued or allocated. One World doesn’t anticipate any changes to the share structure in the foreseeable future.

MAITLAND, Fla., Aug. 16, 2010 (GLOBE NEWSWIRE) — Workstream Inc. (OTCBB:WSTM ) today announced expansion of its management, appointment of a new Board of Directors, new capital structure and additional capital for the human capital technology, software and services company. The changes are expected to result in growth of the business and the introduction of additional products as well as to set a course for possible future acquisitions. In making the announcement, the company outlined plans that are intended to allow the company to become a stronger human capital management business, expanding on the current Workstream Software as a Service (SaaS) offerings.

John Long, former CEO of First Advantage Corporation, will take over as CEO of Workstream, replacing Michael Mullarkey, the founder and current CEO, who will remain with the company. Under Long’s watch, First Advantage Corporation grew from a small division of First American Corporation (NYSE:FAF ) to a stand-alone publicly traded company with over a billion dollar market cap. Workstream will maintain its current headquarters in Maitland, Florida, outside of Orlando.

Workstream offers a set of technology solutions and services to help employers meet challenging human capital issues. The offering includes software and data for recruiting, managing performance reviews, developing competencies for employees, succession planning, communicating with employees about benefits and managing compensation and non-cash rewards programs. A pioneer in the human capital management sector, Workstream has multi-language capabilities that serve a growing international customer base.

Commenting on the move, John Long said: “Workstream is a vibrant company with a suite of innovative human capital technology solutions. The company’s compensation management, performance management and recruiting products are best in class. In addition, the Rewards and Recognition services and 6FigureJobs career site owned by Workstream are exceptional businesses. I have been impressed with the services and look forward to putting the company on a path to growth. Recently, Workstream has expanded the services supplied to current clients and succeeded in landing contracts with new clients.”

Company Founder Michael Mullarkey added: “Workstream has a solid, loyal customer base that relies on its products to manage performance reviews and variable pay, establish individual goals and competencies and other strategic human capital functions, using technology. With John Long on board, an expanded management team and a solid capital structure, we can focus on building out the service offering by responding to our customers. Increasingly, companies are seeking to adopt more of the solutions Workstream offers to help attract and retain talent. The solutions are highly scalable and we believe bring great results to employers.”

A new Board of Directors will guide Workstream: Jeffrey Moss, Chairman of the Board; Biju Kulathakal; Denis Sutton; and CEO John Long. Chairman Jeffrey Moss said: “I am delighted to be a part of this newly re-energized company and participate in its future initiatives. We are fortunate to be in a growing market with an established set of solutions that are in high demand. And we have a management team in place who have successfully executed on growing quality businesses in the human capital sector during their careers.”

Members of the new Board of Directors will be:

• Jeffrey Moss — Chairman of the Board — Chief of Enterprise Growth, Educational Testing Service (ETS), Princeton, New Jersey and Chicago, Illinois;
• Biju Kulathakal — Chairman and CEO of Trading Block Holdings, Inc. — a financial services holding company, based in Chicago, Illinois;
• Denis E. Sutton — Senior Vice President, Human Resources, MTS Allstream — Enterprise Solutions Division, Winnipeg, Manitoba, Canada
• John Long — CEO, Workstream Inc.

Joining Long as part of the management team are David Kennedy, Chief Operating Officer, and Ezra Schneier, Corporate Development Officer. Both worked with Long in similar roles at First Advantage Corporation.

Workstream also announced that it had completed a capital restructuring pursuant to which the holders of its senior secured debt exchanged such debt (totaling approximately $22.4 million) for a total of 682,852,374 common shares in Workstream. In addition, certain of such note holders as well as members of the company’s new management team agreed to invest in the company by purchasing an aggregate $1.25 Million of Workstream’s common shares in a private placement. Following the exchange of the senior secured debt and the issuance of shares in the private placement, Workstream’s former debt holders and new management team will own approximately 92% of the company’s issued and outstanding common shares. As part of the capital restructuring, one of the note holders agreed to loan the company $750,000 pursuant to which the company issued such note holder a new senior secured note. The company expects to use the proceeds for working capital purposes and to expand the business.

“This new capital structure allows us to focus on growth and innovation without being burdened by a heavy debt load,” Long said. With a new capital structure, the company intends to strengthen the business and seek strategic acquisitions to build out the suite of available services and solutions. Long said: “Our strategy is to be the preferred vendor for our clients and bring them the solutions they need to manage a variety of human capital requirements. In this regard, we will look to acquire companies that have top-shelf services and technology that are complementary to the Workstream solutions.”

“The goal for Workstream is to become a larger, more diversified human capital technology and service provider,” Long said. “This is a market that we believe is under-served today. At the same time, the needs of businesses to improve the way they manage HR functions continues to expand. Managing human capital continues to shift from an administrative function to a strategic area for employers, with huge potential returns. We expect Workstream to be right in the middle of helping to enable that shift.”

Continued Long: “We will achieve success by listening to our customers and serving the needs of existing and new clients in the months ahead. Workstream has a combination of great products, state of the art technology, skilled management and staff with a culture that emphasizes customer service. We believe it is a great platform for future growth.”

A Current Report on Form 8-K will be filed with the SEC containing the material terms of the transactions described above and the agreements delivered in connection with such transactions.

One of my preferred straightforward investing strategies for individual investors is to put your retirement funds in a increasing stock. That sounds pretty simple, but many traders fast understand it’s not as simple an investment strategy as it looks — especially while it comes to finding hot penny stocks to buy now. After all, many of the big-name shares to purchase that you hear about every day are huge blue chips that have already seen their biggest growth. And some of the penny stocks that are small up-and-comers are aggressive, risky investments that could cost you all.

So how do you find growing stocks — and specially for smaller investors, the best penny stocks to buy? My advice to you is to look closely at the numbers. That means taking a hard look at earnings, sales and estimates for each investment you think is worthy of your retirement fund.

More than 8000 transplants has been done using Cord Blood since the first transplant in 1988.Families know that there is only one opportunity – at birth – to collect these genetically unique stem cells and if not taken, the cord blood is simply discarded.This technology to collect and store newborn’s umbilical cord blood stem cells has only been widely available since late 1995.Currently, thousands of parents are taking advantage of this once-in-a-lifetime opportunity. For regenerative medicine applications, the child’s own cord blood is required.

Cord Blood preservation is viewed it as a type of “biological insurance” – because these stem cells may be lifesaving to their family, as there are many dieseases cured by cord blood.Families recognize that their baby’s cord blood may offer a lifetime of protection:

• The baby’s cord blood may be used to treat nearly 80 diseases. Stem cells have been used for decades in lifesaving treatments for diseases including leukemia, other cancers, and blood disorders.
• Cord blood stem cells are showing significant potential to treat conditions that have no cure today – like juvenile diabetes and brain injury.
• The baby’s cord blood is immediately available for the family if needed, and faster treatment is always better.
• For use in regenerative medicine therapies using cord blood, the child’s own stem cells are required.
• For treating cancers and blood disorders in transplant medicine, having the family’s own cord blood available may offer significant advantages if ever needed, including fewer complications, improved survival, and a better quality of life without the need for continual anti-rejection medications.

Some families have more defined risk factors, but most families bank for the security of knowing the health benefits that stem cells may someday offer their children, themselves, or other family members.

What is the truth behind the Cord Blood America?

Cord Blood America is a publically traded company and featured in countless news and media coverage.

CBAI has signed a License and Cooperation Agreement for the processing and storage of umbilical cord blood in China with AXM Pharma, Inc.

They are actually located on Helm Drive in Las Vegas and currently hold the record for the largest cryogenic storage facility in the world. Readers must be aware of the Cryogenic technology used in rocket launchers.

Cryogenic pertains to liquefied gases, ie, helium, nitrogen, CO2, which are all inert and extremely cold, ie. -270 deg. Celsius. Others are reactive, LP, Hydrogen.

Information from Importance of Cord Blood Banking

Is it possible for you to make money working online in your spare time using your home computer. Many of these online money making is not requiring any series investing, and no need to have a product or sales and marketing skills. This is a full time and a part time job opportunity for any body who is interested to have a good steady source of income.

There are many advantages for online jobs compared to regular 9 to 5 jobs. Main advantages of online jobs are:

• No more traffic jams as you need not to drive to work everyday.
• Very flexible timing, no need to feel sorry for being late.
• Very suitable for partimers and housewives.
• Can use your spare time for a good cause.

Online money making involves a website designed for this purpose. There are many new untapped programs, which brings money to your account through the website. To make considerable income you have to have decent traffic to your website. It is reasonable to expect your website to bring some extra cash each month. The main revenue sources from websites are:

• Affiliate Programs
• Adsense
• Advertisements

More people are making money online ever than before. By combining the knowledge available at different sources, you can make tones of money by working online.

I’m talking about DAILY INCOME that is automatic.If you have an automated system with all the right instructions, it become easy to navigate in the desert. If you intend to make money online, you need to consider Six figure yearly system first.

Six figure yearly System is unique from other systems. Six figure yearly program is also considered as a big entry into the Adsense and Adwords research market as well as application. It utilizes these two money making utilities to create an extremely effective profitable campaign.

Anybody can use profit Lance system to make money online in their spare time.

Information from Part time online income System

Is it possible for you to make money working online in your spare time. Many of these online money making is not requiring any series investing, and no need to have a product or sales and marketing skills.

Why one prefers online job compared to traditional job? They are:

• Very flexible timing as you are yor own boss.
• No need to drive during the peek hours are there is no commuting involved.
• Very flexible timing.
• Can work part time and suitable for housewives.
• Can use your spare time.

Most online money making methods require you to have a website designed for that. There are different ways to make money online from a website. The main revenue sources from websites are:

• Affiliate Programs
• Advertisements

By harnessing the technology, people are able to make handsome income by working online during spare time.By combining the knowledge available at different sources, you can make tones of money by working online.If you have an automated system with all the right instructions, it become easy to navigate. Profit Lance System may be the best online money making systm.

Profit Lance System is unique from other systems. This system uses the popular Adsense and Adwords to make money online. It utilizes these two moneymaking utilities to create an extremely effective profitable campaign.

Anybody can use profit Lance system to make money online in their spare time.

Information from Complete Review of Work from Home System